title: [Spleen rupture in myocardial infarction after administration of GP IIb-IIIa-antagonists].
authors.affiliation: Medizinische Klinik I, St. Katharinen Hospital Frechen. Feldmann@khs-frechen.de
authors.forename: C
authors.initials: C
authors.lastname: Feldmann
authors.forename: H J
authors.initials: HJ
authors.lastname: Deutsch
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D000077144:Clopidogrel; D017023:Coronary Angiography; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013156:Splenectomy; D013161:Splenic Rupture / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery; D015607:Stents; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077466:Tirofiban; D014057:Tomography, X-Ray Computed; D014443:Tyrosine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D006493:Heparin; D000077144:Clopidogrel; D000077466:Tirofiban; D013988:Ticlopidine